NIH-funded study suggests that testosterone suppresses brain tumor growth in males
Clinical Scorecard: NIH-Supported Research Indicates Testosterone May Inhibit Brain Tumor Progression in Men
At a Glance
| Category | Detail |
|---|
| Condition | Glioblastoma |
| Key Mechanisms | Testosterone may suppress tumor growth by regulating the hypothalamus-pituitary-adrenal (HPA) axis and reducing local inflammation. |
| Target Population | Men with glioblastoma |
| Care Setting | Clinical research and potential treatment settings |
Key Highlights
- Loss of testosterone linked to increased glioblastoma growth due to inflammation.
- Supplemental testosterone associated with a 38% lower risk of death in men with glioblastoma.
- Androgens play a crucial role in maintaining brain immune environment.
Guideline-Based Recommendations
Diagnosis
- Consider testosterone levels in the assessment of glioblastoma in men.
Management
- Explore testosterone supplementation as a potential adjunct therapy for glioblastoma.
Monitoring & Follow-up
- Monitor testosterone levels and associated clinical outcomes in glioblastoma patients.
Risks
- Evaluate the impact of androgen deprivation therapy on glioblastoma progression.
Patient & Prescribing Data
Men diagnosed with glioblastoma
Supplemental testosterone may improve survival outcomes.
Clinical Best Practices
- Conduct clinical trials to investigate the effects of testosterone on glioblastoma.
- Assess the role of the HPA axis in glioblastoma progression.
Related Resources & Content
